GLAZER CAPITAL, LLC - C B PHARMA ACQUISITION CORP ownership

C B PHARMA ACQUISITION CORP's ticker is CNLM and the CUSIP is G2029P126. A total of 9 filers reported holding C B PHARMA ACQUISITION CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GLAZER CAPITAL, LLC ownership history of C B PHARMA ACQUISITION CORP
ValueSharesWeighting
Q4 2015$224,000
-1.8%
21,8240.0%0.03%
+17.9%
Q3 2015$228,000
-0.9%
21,8240.0%0.03%
+12.0%
Q2 2015$230,000
-89.4%
21,824
-90.1%
0.02%
-92.3%
Q1 2015$2,163,000220,2600.33%
Other shareholders
C B PHARMA ACQUISITION CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Weiss Asset Management LP 423,246$4,211,0001.07%
Polar Asset Management Partners Inc. 550,000$5,472,0000.28%
Karpus Management, Inc. 131,601$1,309,0000.06%
AQR Arbitrage LLC 350,000$3,483,0000.04%
GLAZER CAPITAL, LLC 21,824$224,0000.03%
Yakira Capital Management, Inc. 12,500$124,0000.03%
UBS Group AG 1,233$12,0000.00%
Tower Research Capital LLC (TRC) 203$2,0000.00%
MORGAN STANLEY 10$00.00%
View complete list of C B PHARMA ACQUISITION CORP shareholders